Arbutus Pharma(ABUS.US)

Last Updated 19:00:00 ET
longbridge loading

Key facts: ABUS Q1 $179.1M revenue; $169.7M net, $0.05 adj loss

TradingView·
US
MRNA
-4.97%
US
ABUS
+0.72%
US
BIB
+0.05%
TradingView·
US
MRNA
-4.97%
US
ABUS
+0.72%
US
BIB
+0.05%

Arbutus Pharma | 10-Q: FY2026 Q1 Revenue: USD 179.13 M

Earnings Watch·
US
ABUS
+0.72%
Earnings Watch·
US
ABUS
+0.72%

Arbutus Pharma | 8-K: FY2026 Q1 Revenue: USD 179.13 M

Earnings Watch·
US
ABUS
+0.72%
Earnings Watch·
US
ABUS
+0.72%

Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update | ABUS Stock News

StockTitan·
US
ABUS
+0.72%
StockTitan·
US
ABUS
+0.72%

QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

benzinga_article·
US
GEVO
-3.45%
US
ABUS
+0.72%
US
BIRD
-0.25%
benzinga_article·
US
GEVO
-3.45%
US
ABUS
+0.72%
US
BIRD
-0.25%
© 2026 Longbridge｜Disclaimer